These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11158403)

  • 1. Reduced venous responsiveness to endothelin-1 but not noradrenaline in hypertensive chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Nephrol Dial Transplant; 2001 Feb; 16(2):295-301. PubMed ID: 11158403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.
    Haynes WG; Hand MF; Johnstone HA; Padfield PL; Webb DJ
    J Clin Invest; 1994 Oct; 94(4):1359-64. PubMed ID: 7929810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous endothelin receptor function in patients with chronic heart failure.
    Love MP; Haynes WG; Webb DJ; McMurray JJ
    Clin Sci (Lond); 2000 Jan; 98(1):65-70. PubMed ID: 10600660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
    Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
    Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P
    Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins.
    Blöchl-Daum B; Vierhapper H; Eichler HG; Waldhäusl W
    Arch Int Pharmacodyn Ther; 1992; 316():90-6. PubMed ID: 1530376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
    Sudano I; Virdis A; Taddei S; Spieker L; Corti R; Noll G; Salvetti A; Luscher TF
    Hypertension; 2007 Feb; 49(2):285-90. PubMed ID: 17178974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA; Stauffer BL; Brunjes DL; Greiner JJ; DeSouza CA
    Exp Physiol; 2017 Sep; 102(9):1133-1142. PubMed ID: 28635124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY
    Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin in hypertension of experimental chronic renal failure.
    Potter GS; Johnson RJ; Fink GD
    Hypertension; 1997 Dec; 30(6):1578-84. PubMed ID: 9403586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of age on human venous responsiveness to neuropeptide Y.
    Lambert ML; Callow ID; Feng QP; Arnold JM
    Br J Clin Pharmacol; 1999 Jan; 47(1):83-9. PubMed ID: 10073744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venoconstriction to endothelin-1 in humans is attenuated by local generation of prostacyclin but not nitric oxide.
    Webb DJ; Haynes WG
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S317-20. PubMed ID: 7509975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.